Search
for
Sort by
Research 721–750 of 1000+
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- CLINICAL PROFILE AND OUTCOMES OF PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME
- Glucocorticoid Resistance Syndrome in 2 Patients With Diverse Genotype
- Multiple sclerosis: Side effects of interferon beta therapy and their management
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Tinea Capitis: An Overview with Emphasis on Management
- Evaluation and diagnosis of the hair loss patient
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management
- Acne in the adult female patient: a practical approach
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Impact on the quality of life of dermatological patients in southern Brazil
- Novel drug delivery approaches for the management of hair loss
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- The Hirsute Woman: Challenges in Evaluation and Management
- Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016–2023)
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management
- Health‐related quality of life (hrQoL) among patients with primary cicatricial alopecia (PCA): A systematic review
- Metabolic syndrome — a new definition and management guidelines
- Frequency and associated factors of hair loss among patients with inflammatory bowel disease
- Survey on adverse events associated with drug therapy for breast cancer patients
- Prevalence Study of Dermatologic Manifestations among Diabetic Patients
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Alopecia Areata Is Associated with Posttraumatic Stress Disorder and Alcohol Use in a Case-Control Study of 4,785 Patients
- [Translated article] Characteristics, Management, and Prognostic Implications of Adverse Effects of Immune Checkpoint Inhibitors: A Systematic Review
- Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, UK perspective
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Somatization in the dermatology patient: Some sociocultural perspectives